. 2001 Apr 10;1:2. doi: 10.1186/1471-2326-1-2

Table 2.

Distribution of tumor necrosis factor (TNF) and lymphotoxin-α (LT-α) genotypes and their association with the occurrence of relapse in 64 case subjects and 64 successfully treated matched control subjects with acute lymphoblastic leukemia from ALL-BFM trials 86 and 90

	Cases (%)	Controls (%)	OR^a (95 % CI^b)	P value
TNF
TNF1/TNF1	41 (64.1)	43 (67.2)	1.00
TNF1/TNF2	21 (32.8)	20 (31.3)	1.17^c (0.53-2.56)	0.697
TNF2/TNF2	2 (3.1)	1 (1.6)
LT-α
10.5 kb/10.5 kb	25 (39.1)	30 (46.9)	1.00
10.5 kb/5.5 kb	32 (50.0)	23 (35.9)	2.17 ^d (0.84-5.58)	0.107
5.5 kb/5.5 kb	7 (10.9)	11 (17.2)	0.50 ^d (0.09-2.66)	0.418

^a odds ratio ^b confidence interval ^c odds ratio for the combined category of TNF1/TNF2 and TNF2/TNF2 genotypes ^d odds ratio for the combined category of LT-α (10.5 kb/5.5 kb) and LT-α (5.5 kb/5.5 kb) with reference to LT-α (10.5 kb/10.5 kb) was 1.5 (95% CI = 0.68-3.32; P = 0.317)